Your cart is empty
TB-500 / BPC-157 / KPV Recovery Blend
Also known as CoreMend
Coremend is a research blend combining TB-500 (thymosin beta-4 fragment), BPC-157, and the tripeptide KPV in a single preparation, studied for converging tissue-repair and inflammatory-signaling pathways.
5 vials — 12% bulk discount applied at checkout
Maximum available: 1 × 5-Pack (5 vials)
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
Coremend is a research blend combining TB-500 (thymosin beta-4 fragment), BPC-157, and the tripeptide KPV in a single preparation, studied for converging tissue-repair and inflammatory-signaling pathways.
Each component is independently characterized in the laboratory literature; the blend is studied as a combined preparation.
Coremend combines three research peptides associated with structural-repair and inflammatory-modulation pathways: TB-500 (cellular migration and actin regulation), BPC-157 (angiogenic and cytoprotective signaling), and KPV (anti-inflammatory α-MSH-fragment activity). Research framing draws on the established literature for each component.
The blend is studied as a combined preparation in tissue-repair research models under structured conditions.
Coremend is formulated from three independently studied research peptides. Its components — TB-500, BPC-157, and KPV — each have distinct research lineages in structural-repair and inflammatory-signaling models.
Research framing for Coremend draws on the combined literature of its components across cellular-migration, angiogenic, cytoprotective, and anti-inflammatory pathway models under controlled conditions.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each unit contains the labeled quantity of coremend. Independent third-party analysis verifies purity, identity, and net content per batch.
The unit contains only the research compound. Any laboratory materials required for reconstitution or experimental procedures must be sourced separately.
Duration depends entirely on research design, storage conditions, and laboratory protocol.
Thymosin beta4 accelerates wound healing. J Invest Dermatol 113(3):364–368.
PubMedA new gastric juice peptide, BPC. An overview of the stomach-stress-organoprotection hypothesis and beneficial effects of BPC. J Physiol Paris 87(5):313–327.
PubMedOrally targeted delivery of tripeptide KPV via hyaluronic acid-functionalized nanoparticles efficiently alleviates ulcerative colitis.
PubMedRelated

Studied in metabolic research for its effects on glucose regulation, appetite signaling, and energy balance.
From$70.00

Dual incretin receptor agonist studied for glucose regulation, metabolic signaling, and weight pathway research
From$50.00

Immune-modulating peptide studied for T-cell signaling and immune system regulatory pathway research
From$60.00

GHRH analog studied for growth hormone regulation and metabolic pathway signaling research
From$90.00